Related Experiment Video
Updated: May 26, 2025

10:32
Development of a Virtual Reality Assessment of Everyday Living Skills
Published on: April 23, 2014
18.3K
Twenty Years of the NIMH Measurement and Treatment Research to Improve Cognition in Schizophrenia
1Department of Psychiatry, University of Maryland School of Medicine, Baltimore, MD 21228, United States.
Schizophrenia Bulletin
|February 21, 2025
Abstract
No abstract available in PubMed .
Related Concept Videos
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
95
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
95
Alzheimer's Disease: Treatment
149
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
149

